The Reply to the Letter to the Editor Regarding: "The Autologous CaTeVac Dendritic Cell Vaccine in Patients with Melanoma: Final Results of the DENDRON-01 Study". Вопр. онкол. [Internet]. 2026 Mar. 11 [cited 2026 Oct. 14];72(1):OF-2568. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/1-26-Reply-to-the-Letter